FDA Inspection 924723 — Ingenus Pharmaceuticals NJ, LLC.

Ingenus Pharmaceuticals NJ, LLC. — FEI 2246963

The FDA completed an inspection of Ingenus Pharmaceuticals NJ, LLC. on May 4, 2015 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 4, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fairfield, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
683121 CFR 314.80(c)(2)Late submission of quarterly safety reports